Fmn2 expression was found to be reduced in postmortem brain samples of patients with posttraumatic stress disorder and Alzheimer’s disease (Agís‐Balboa et al., 2017). The gene discussed is FMN2; the disease is early-onset autosomal dominant Alzheimer disease.